Multiple Sclerosis Co-Pay Relief Program Adds New Prescription Coverage

The Co-Pay Relief program offered through the Patient Advocate Foundation has added a new financial assistance fund to its collection of resources for patients with multiple sclerosis (MS). The new fund is now available to financially eligible MS patients with health insurance coverage to support the costs of necessary treatment medicines.

“Our case management department has been supporting those living with MS for years, and our data shows that medication copayments connected with chronic disease can create significant financial burden for patients and their families. This program will provide MS patients with critical financial assistance that will help them get and stay on the treatment recommended by their prescribing physician,” Alan Balch, PhD, chief executive officer at the Patient Advocate Foundation, said in a press release.

According to The Multiple Sclerosis Association of America, nearly 400,000 people in the U.S. have multiple sclerosis, a demyelinating disease in which the insulating cover (called myelin) of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a wide range of symptoms, including fatigue, balance issues, tremors, muscle weakness, numbness, vision loss, depression, and bowel and bladder control problems. MS affects differently each person with different levels of disease severity.

Learn more

helps to provide educational information for persons affected by MS